244 related articles for article (PubMed ID: 25091505)
21. Activated platelets contribute to stimulation of cardiac afferents during ischaemia in cats: role of 5-HT(3) receptors.
Fu LW; Longhurst JC
J Physiol; 2002 Nov; 544(3):897-912. PubMed ID: 12411532
[TBL] [Abstract][Full Text] [Related]
22. The involvement of 5-HT2-receptor sites in the activation of cat platelets.
De Clerck F; Xhonneux B; Leysen J; Janssen PA
Thromb Res; 1984 Feb; 33(3):305-21. PubMed ID: 6710435
[TBL] [Abstract][Full Text] [Related]
23. Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation.
Tseng YL; Chiang ML; Lane HY; Su KP; Lai YC
Thromb Res; 2013 Apr; 131(4):325-32. PubMed ID: 23490430
[TBL] [Abstract][Full Text] [Related]
24. Involvement of platelet-derived 5-hydroxytryptamine in thromboxane A2-induced aggregation in cat platelets.
Ogawa T; Sugidachi A; Asai F; Koike H
Blood Coagul Fibrinolysis; 1998 Apr; 9(3):233-40. PubMed ID: 9663705
[TBL] [Abstract][Full Text] [Related]
25. Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice.
Yamashita M; Fukushima S; Shen HW; Hall FS; Uhl GR; Numachi Y; Kobayashi H; Sora I
Neuropsychopharmacology; 2006 Oct; 31(10):2132-9. PubMed ID: 16407898
[TBL] [Abstract][Full Text] [Related]
26. 5-Hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats.
Awabdy D; Bryan-Lluka LJ; Wanstall JC
Eur J Pharmacol; 2003 Jan; 459(1):1-7. PubMed ID: 12505528
[TBL] [Abstract][Full Text] [Related]
27. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
Storey RF; Sanderson HM; White AE; May JA; Cameron KE; Heptinstall S
Br J Haematol; 2000 Sep; 110(4):925-34. PubMed ID: 11054084
[TBL] [Abstract][Full Text] [Related]
28. 5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor.
Shelton J; Bonaventure P; Li X; Yun S; Lovenberg T; Dugovic C
Neuropharmacology; 2009 Feb; 56(2):448-54. PubMed ID: 18948124
[TBL] [Abstract][Full Text] [Related]
29. Characterization of rat platelet serotonin receptors with tryptamine agonists and the antagonists: ketanserin and SCH 23390.
Killam AL; Cohen ML
Thromb Res; 1991 Nov; 64(3):331-40. PubMed ID: 1805448
[TBL] [Abstract][Full Text] [Related]
30. Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation.
Larsen MB; Sonders MS; Mortensen OV; Larson GA; Zahniser NR; Amara SG
J Neurosci; 2011 Apr; 31(17):6605-15. PubMed ID: 21525301
[TBL] [Abstract][Full Text] [Related]
31. [3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux.
Johnson RA; Eshleman AJ; Meyers T; Neve KA; Janowsky A
Synapse; 1998 Sep; 30(1):97-106. PubMed ID: 9704886
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444.
Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Asai F
Eur J Pharmacol; 2002 Dec; 457(2-3):107-14. PubMed ID: 12464356
[TBL] [Abstract][Full Text] [Related]
33. Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter.
Thompson BJ; Jessen T; Henry LK; Field JR; Gamble KL; Gresch PJ; Carneiro AM; Horton RE; Chisnell PJ; Belova Y; McMahon DG; Daws LC; Blakely RD
Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3785-90. PubMed ID: 21282638
[TBL] [Abstract][Full Text] [Related]
34. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
[TBL] [Abstract][Full Text] [Related]
35. High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy.
Kéreveur A; Callebert J; Humbert M; Hervé P; Simonneau G; Launay JM; Drouet L
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2233-9. PubMed ID: 11031209
[TBL] [Abstract][Full Text] [Related]
36. Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs.
Bismuth-Evenzal Y; Gonopolsky Y; Gurwitz D; Iancu I; Weizman A; Rehavi M
J Affect Disord; 2012 Jan; 136(1-2):99-103. PubMed ID: 21893349
[TBL] [Abstract][Full Text] [Related]
37. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
Knobelman DA; Hen R; Blendy JA; Lucki I
J Pharmacol Exp Ther; 2001 Sep; 298(3):1092-100. PubMed ID: 11504806
[TBL] [Abstract][Full Text] [Related]
38. The selective serotonin reuptake inhibitor citalopram induces the storage of serotonin in catecholaminergic terminals.
Suarez-Roca H; Cubeddu LX
J Pharmacol Exp Ther; 2002 Jul; 302(1):174-9. PubMed ID: 12065714
[TBL] [Abstract][Full Text] [Related]
39. Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity.
Mannoury la Cour C; Boni C; Hanoun N; Lesch KP; Hamon M; Lanfumey L
J Neurosci; 2001 Mar; 21(6):2178-85. PubMed ID: 11245702
[TBL] [Abstract][Full Text] [Related]
40. Differential serotonergic inhibition of in vitro striatal [3H]acetylcholine release in prenatally cocaine-exposed male and female rats.
Bolaños CA; Trksak GH; Cohen OS; Jackson D
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1339-48. PubMed ID: 12502023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
